Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Triomics
AddedApr 3, 2024
UpdatedJun 18, 2026
Triomics

Triomics

Series A

Triomics: AI-driven oncology care, enhancing patient-trial matching & data curation.

HQ
San Francisco, CA, US
Founded
2020
Accelerator
Y Combinator logoY CombinatorW21
Overview
Compare
Fundraising
Employees
News
Website

Triomics, founded with a mission to revolutionize oncology research and care through intelligent automation, focuses on leveraging AI to assist cancer care providers. The company offers a generative AI-powered platform designed to manage the growing volume of oncology data, reduce cognitive overload for healthcare staff, and streamline operations. Triomics' solutions include enhancing patient-trial matching, curating data for research and precision medicine, and accelerating trial enrollment and quality improvement projects.

Notable affiliated individuals and investors in Triomics include experts in oncology and AI technology, though specific names are not provided. The company has achieved significant milestones in improving the efficiency of oncology care operations and has made a substantial impact by enabling faster trial enrollments and better data management. Triomics' AI-driven approach has positioned it as a key player in transforming cancer care and research, addressing critical challenges faced by healthcare providers.

Triomics - Similar Companies

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

GenomOncology logo

GenomOncology

genomoncology.com

Onc.AI logo

Onc.AI

onc.ai

xCures logo

xCures

xcures.com

Massive Bio logo

Massive Bio

massivebio.com

Nest Genomics logo

Nest Genomics

nestgenomics.com

OmicsChart logo

OmicsChart

omicschart.com

Cambridge Cancer Genomics logo

Cambridge Cancer Genomics

VieCure logo

VieCure

viecure.com

Leal Health logo

Leal Health

leal.health

Precision Health AI logo

Precision Health AI

Known Medicine logo

Known Medicine

ConcertAI logo

ConcertAI

concertai.com

Vysioneer logo

Vysioneer

vysioneer.com

Data Driven Bioscience logo

Data Driven Bioscience

Triomics - Quick Facts

Who are Triomics' competitors?

Companies similar to Triomics include Biogenesis Trials, GenomOncology, Onc.AI and xCures.

When was Triomics founded?

Triomics was founded in 2020.

Where is Triomics' headquarters located?

Triomics' headquarters is located in San Francisco, CA, US.

When was Triomics' last funding round?

Triomics' most recent funding round was for $11.3M (USD) in February 2023.

How much has Triomics raised to-date?

As of Feb 22, 2023, Triomics has raised a total of $14.1M (USD).

How many employees does Triomics have?

Triomics has 50 employees as of Mar 31, 2024.

Triomics - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Oncology Software
Tags
  • AI Operations
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541500Computer Systems Design and Related Services
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 8000Health Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7371Computer Programming Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified